Fact CheckerSign in

NCT07436351Recruiting

ACT With CF Self-Help Toolkit

Source: ClinicalTrials.gov · Last updated 3 Mar 2026

Brief summary (registry, in English)

Acceptance and Commitment Therapy (ACT) tailored to meet the needs of adults living with cystic fibrosis (ACT with CF) is a newer form of talk therapy that has been shown to reduce anxiety \& depression and improve psychological flexibility, and value-based living. The investigators are now trying to find out whether a self-help version of this treatment (ACT with CF - Self Help Toolkit) is also effective in reducing anxiety and depression and improving psychological flexibility and value-based living in adults with CF. Adults with cystic fibrosis are at increased risk for anxiety and depression. This study examines whether a patient-facing therapy, ACT with CF - Self Help Toolkit can help to reduce anxiety and depression among adults with CF. This treatment can be accessed on the participant's smartphone.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
60 (estimated)
First submitted
20 Feb 2026
Start date
Jan 2026
Primary completion date
Apr 2027
Lead sponsor
Thomas Jefferson University
NCT number
NCT07436351

What you commit to

  • Study type: Interventional
  • Planned participants: 60
  • From Jan 2026 to the primary completion date, Apr 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of suicide attempts or acute suicidal ideation on clinical assessment
  • Presence of psychotic disorder or symptoms
  • Presence of psychiatric disorders that interfere with participation in the study, judged by the study or treating clinician
  • Presence of other medical conditions that interfere with participation in the study, judged by the study or treating clinician

Who the study is looking for

  • 18 years or older
  • Existing diagnosis of cystic fibrosis
  • PHQ-9 score \>4 or GAD-7 score \>4

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Thomas Jefferson University Hospital
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.